Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

Fig. 1

Flowchart for patients enrollment. A total of 288 at 12–34 weeks of gestation women with chronic hepatitis B were screened, 23 patients did not meet the eligibility criteria and were excluded. In the remaining 265 individuals, there were 143 patients in telbivudine group and 122 patients in control group. However, 4 patients and 20 patients withdrew from the study in each group, respectively. Therefore, there were 139 patients in telbivudine group and 102 patients in control group in our study cohort finally

Back to article page